Pandect Bioventures Asset Manager Profile - aVenture Research
Pandect Bioventures is a venture capital firm specializing in funding early-stage biotech and pharma companies. The firm provides investments ranging from seed to Series A and later rounds, supporting startups through various stages of their growth. Pandect Bioventures rigorously assesses opportunities to ensure they align with their strategic focus on innovative healthcare solutions.
Notable portfolio companies include Circle Pharma, which has raised $66 million, and Valitor, with $28 million in funding. The firm boasts top academic and industry advisors who contribute extensive experience in company formation and growth. Additionally, Pandect offers unique value-add services such as access to a state-of-the-art incubator facility and exclusive collaborations with leading research institutions, enhancing the development potential of their portfolio companies.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.
